Infection and Immunity, July 1994, p. 2857-2864, Vol. 62, No. 7
0019-9567/1994/$04.00+0 DOI:
Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan.
D C Houpt,
G S Pfrommer,
B J Young,
T A Larson, and
T R Kozel
Department of Microbiology, University of Nevada, Reno 89557.
ABSTRACT
Serum obtained from normal human subjects contains antibodies reactive in an enzyme-linked immunosorbent assay with the glucuronoxylomannan (GXM) of Cryptococcus neoformans. The frequency of occurrence of class-specific antibodies among normal subjects was 28% for immunoglobulin G (IgG), 98% for IgM, and 3% for IgA. Anti-GXM antibodies with kappa light chains occurred in 98% of normal subjects, while the occurrence of lambda light chains was 28%. Each of five subjects with high levels of anti-GXM IgG antibodies had readily detectable antibodies of the IgG2 isotype; two of the five subjects had readily detectable IgG1 antibody. An examination of sera from human immunodeficiency virus-infected patients showed that human immunodeficiency virus infection was accompanied by a significant decrease in the occurrence of IgM antibodies and anti-GXM antibodies with kappa light chains; these decreases occurred early in infection when CD4 counts were still > or = 500 cells per microliter. A slight but not statistically significant decrease in the occurrence of anti-GXM IgG antibodies was seen only in patients with CD4 levels of < 200 cells per microliter. Sera from normal subjects with high levels of anti-GXM IgG antibodies were examined to identify any contribution of the antibodies to complement activation or to opsonization of the yeast cells. An analysis of the kinetics for activation and binding of C3 to the yeast cell showed no pattern of quantitative or qualitative differences between sera with high or low levels of anti-GXM IgG antibodies. Phagocytosis studies showed that the naturally occurring IgG antibodies did not contribute to opsonization of the yeast cells.
Infection and Immunity, July 1994, p. 2857-2864, Vol. 62, No. 7
0019-9567/1994/$04.00+0 DOI:
This article has been cited by other articles:
-
Monari, C., Kozel, T. R., Paganelli, F., Pericolini, E., Perito, S., Bistoni, F., Casadevall, A., Vecchiarelli, A.
(2006). Microbial Immune Suppression Mediated by Direct Engagement of Inhibitory Fc Receptor. J. Immunol.
177: 6842-6851
[Abstract]
[Full Text]
-
Jalali, Z., Ng, L., Singh, N., Pirofski, L.-a.
(2006). Antibody Response to Cryptococcus neoformans Capsular Polysaccharide Glucuronoxylomannan in Patients after Solid-Organ Transplantation.. CVI
13: 740-746
[Abstract]
[Full Text]
-
Gates, M. A., Kozel, T. R.
(2006). Differential Localization of Complement Component 3 within the Capsular Matrix of Cryptococcus neoformans.. Infect. Immun.
74: 3096-3106
[Abstract]
[Full Text]
-
Subramaniam, K., French, N., Pirofski, L.-a.
(2005). Cryptococcus neoformans-Reactive and Total Immunoglobulin Profiles of Human Immunodeficiency Virus-Infected and Uninfected Ugandans. CVI
12: 1168-1176
[Abstract]
[Full Text]
-
Monari, C., Pericolini, E., Bistoni, G., Casadevall, A., Kozel, T. R., Vecchiarelli, A.
(2005). Cryptococcus neoformans Capsular Glucuronoxylomannan Induces Expression of Fas Ligand in Macrophages. J. Immunol.
174: 3461-3468
[Abstract]
[Full Text]
-
Tissi, L., Puliti, M., Bistoni, F., Mosci, P., Kozel, T. R., Vecchiarelli, A.
(2004). Glucuronoxylomannan, the Major Capsular Polysaccharide of Cryptococcus neoformans, Inhibits the Progression of Group B Streptococcal Arthritis. Infect. Immun.
72: 6367-6372
[Abstract]
[Full Text]
-
Monari, C., Kozel, T. R., Bistoni, F., Vecchiarelli, A.
(2002). Modulation of C5aR Expression on Human Neutrophils by Encapsulated and Acapsular Cryptococcus neoformans. Infect. Immun.
70: 3363-3370
[Abstract]
[Full Text]
-
Retini, C., Kozel, T. R., Pietrella, D., Monari, C., Bistoni, F., Vecchiarelli, A.
(2001). Interdependency of Interleukin-10 and Interleukin-12 in Regulation of T-Cell Differentiation and Effector Function of Monocytes in Response to Stimulation with Cryptococcus neoformans. Infect. Immun.
69: 6064-6073
[Abstract]
[Full Text]
-
Nakouzi, A., Valadon, P., Nosanchuk, J., Green, N., Casadevall, A.
(2001). Molecular Basis for Immunoglobulin M Specificity to Epitopes in Cryptococcus neoformans Polysaccharide That Elicit Protective and Nonprotective Antibodies. Infect. Immun.
69: 3398-3409
[Abstract]
[Full Text]
-
MacGill, T. C., MacGill, R. S., Kozel, T. R.
(2001). Capsular Reactions of Cryptococcus neoformans with Polyspecific and Oligospecific Polyclonal Anticapsular Antibodies. Infect. Immun.
69: 1189-1191
[Abstract]
[Full Text]
-
Merkel, G. J., Scofield, B. A.
(1999). An Opsonizing Monoclonal Antibody That Recognizes a Noncapsular Epitope Expressed on Cryptococcus neoformans. Infect. Immun.
67: 4994-5000
[Abstract]
[Full Text]
-
Syme, R. M., Bruno, T. F., Kozel, T. R., Mody, C. H.
(1999). The Capsule of Cryptococcus neoformans Reduces T-Lymphocyte Proliferation by Reducing Phagocytosis, Which Can Be Restored with Anticapsular Antibody. Infect. Immun.
67: 4620-4627
[Abstract]
[Full Text]
-
Vecchiarelli, A., Retini, C., Casadevall, A., Monari, C., Pietrella, D., Kozel, T. R.
(1998). Involvement of C3a and C5a in Interleukin-8 Secretion by Human Polymorphonuclear Cells in Response to Capsular Material of Cryptococcus neoformans. Infect. Immun.
66: 4324-4330
[Abstract]
[Full Text]
-
Casadevall, A., Cleare, W., Feldmesser, M., Glatman-Freedman, A., Goldman, D. L., Kozel, T. R., Lendvai, N., Mukherjee, J., Pirofski, L.-a., Rivera, J., Rosas, A. L., Scharff, M. D., Valadon, P., Westin, K., Zhong, Z.
(1998). Characterization of a Murine Monoclonal Antibody to Cryptococcus neoformans Polysaccharide That Is a Candidate for Human Therapeutic Studies. Antimicrob. Agents Chemother.
42: 1437-1446
[Abstract]
[Full Text]
-
Kozel, T. R., deJong, B. C. H., Grinsell, M. M., MacGill, R. S., Wall, K. K.
(1998). Characterization of Anticapsular Monoclonal Antibodies That Regulate Activation of the Complement System by the Cryptococcus neoformans Capsule. Infect. Immun.
66: 1538-1546
[Abstract]
[Full Text]
-
Retini, C., Vecchiarelli, A., Monari, C., Bistoni, F., Kozel, T. R.
(1998). Encapsulation of Cryptococcus neoformans with Glucuronoxylomannan Inhibits the Antigen-Presenting Capacity of Monocytes. Infect. Immun.
66: 664-669
[Abstract]
[Full Text]
-
Zhong, Z., Pirofski, L.-a.
(1998). Antifungal Activity of a Human Antiglucuronoxylomannan Antibody. CVI
5: 58-64
[Abstract]
[Full Text]
-
Yuan, R., Casadevall, A., Oh, J., Scharff, M. D.
(1997). T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. USA
94: 2483-2488
[Abstract]
[Full Text]
Copyright © 1994 by the American Society for Microbiology. All rights reserved.